Labcorp Holdings' stock rose by 1.49%, driven by FDA-approved innovations in women's health screening and improved financial performance. The company's strategic acquisitions and collaborations contributed to its growth, making it a strong player in the genomics sector.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing